Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

UBS Maintains Buy on Life360, Lowers Price Target to $110

Author: Benzinga Newsdesk | November 11, 2025 03:51pm

UBS analyst Chris Kuntarich maintains Life360 (NASDAQ:LIF) with a Buy and lowers the price target from $120 to $110.

Posted In: LIF